COMMUNIQUÉS West-GlobeNewswire

Allscripts to sell its interests in Netsmart
10/12/2018
CHICAGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, today announced that it has signed a definitive agreement to sell its interests in Netsmart [...]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10/12/2018
SANTA BARBARA, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on December 5, 2018, the Compensation Committee of [...]
Introducing The Diamond CBD Referral Program Give $25 and Receive $25 by Referring a Friend
10/12/2018
FT LAUDERDALE, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Diamond CBD, Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN ) is pleased to announce the successful introduction to [...]
Nkarta Therapeutics Announces Appointment of Matthew Plunkett, Ph.D., as Chief Financial Officer
10/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held cell therapy company developing engineered Natural Killer (NK) immune cells to fight cancer, today announced that [...]
Genocea Appoints Girish Aakalu, Ph.D., Chief Business Officer
10/12/2018
Role to focus on business development as Genocea expands its immunotherapy pipeline and explores additional applications of its ATLAS™ neoantigen identification platform CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE [...]
Catalyst Biosciences to Host a Research & Development Day Focused on Factor VIIa and Factor IX Hemophilia Programs
10/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Molina Healthcare Selects Inovalon to Provide Data-Driven Insights to Improve Member Care
10/12/2018
Leading Health Plan Applies Inovalon ONE® Platform Capabilities Across All Product Lines BOWIE, Md., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud- [...]
CBT Pharmaceuticals and Strata Oncology Announce Collaboration to Accelerate Development of CBT-101, a c-Met inhibitor, for Patients with Non-Small Cell Lung Cancer and other Solid Tumors
10/12/2018
PLEASANTON, Calif., HANGZHOU, China and ANN ARBOR, Mich., Dec. 10, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), Inc., a U.S. and China-based innovative pharmaceutical company, and Strata Oncology, Inc., a [...]
Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®
10/12/2018
NORTHVALE, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
Onconova Welcomes Avi Oler, JD, MBA, as Vice President, Corporate Development and General Counsel
10/12/2018
Mr. Oler joins Onconova’s management team as Vice President, Corporate Development and General Counsel, after an impactful tenure at Spectrum Pharmaceuticals Hiring reflects Onconova’s commitment to execute business [...]
Novan Announces Full Top Line Results from Phase 2 Molluscum Contagiosum Clinical Trial and Decision to Move Forward with SB206 12% Once-Daily
10/12/2018
SB206 12% once-daily achieved the highest rate of complete clearance out of all active treatment groups at Week 12 (p<0.05) Statistically significant reductions in molluscum lesions as early as Week 2 with 12% once- [...]
Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression
10/12/2018
Ganaxolone was safe and well-tolerated Ganaxolone IV demonstrated fast-acting, robust and durable efficacy Interim data with ganaxolone oral supports IV to oral administration Conference call to be held today at 8:30 AM [...]
Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND
10/12/2018
Baseline Characteristics and Demographics from FORTITUDE-ALS Similar to Other Recent Large Trials in ALS SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today [...]
Apotheca Biosciences (PCFP) Announces the Roll Out of Apotheca Earth, Direct to Business & Consumer Medical Grade CBD Products - Apotheca Earth to Begin National Sales & Marketing Campaign
10/12/2018
SAINT PETERSBURG, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations, and cannabis delivery [...]
Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease
10/12/2018
CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
IMV Announces Updated Clinical Data Presentation for Lead Candidate DPX-Survivac’s Phase 1b/2 Immunotherapy Combination Trial at the ESMO Immuno-Oncology Congress 2018
10/12/2018
IMV to host an investor call on Thursday, December 13 at 8:30 a.m. ET to discuss the presentation DARTMOUTH, Nova Scotia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno- [...]
Resonant Inc. Launches Filter IP Standard Library; Leading Power Amplifier Vendor Licenses First Fast-Track Quadplexer Solution from the Library
10/12/2018
Existing fabless customer expands relationship with license agreement GOLETA, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends [...]
ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10
10/12/2018
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder
10/12/2018
Company’s Deep Transcranial Magnetic Stimulation System is One of Only Eight Products Selected from Over 250 Applications for Potential Treatment of Opioid Use Disorder HACKENSACK, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE [...]

Pages